BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37179034)

  • 1. A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned.
    Aleman BMP; Ricardi U; van der Maazen RWM; Meijnders P; Beijert M; Boros A; Izar F; Janus CPM; Levis M; Martin V; Specht L; Corning C; Clementel E; Raemaekers JM; André MP; Federico M; Fortpied C; Girinsky T
    Int J Radiat Oncol Biol Phys; 2023 Nov; 117(3):664-674. PubMed ID: 37179034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.
    André MPE; Girinsky T; Federico M; Reman O; Fortpied C; Gotti M; Casasnovas O; Brice P; van der Maazen R; Re A; Edeline V; Fermé C; van Imhoff G; Merli F; Bouabdallah R; Sebban C; Specht L; Stamatoullas A; Delarue R; Fiaccadori V; Bellei M; Raveloarivahy T; Versari A; Hutchings M; Meignan M; Raemaekers J
    J Clin Oncol; 2017 Jun; 35(16):1786-1794. PubMed ID: 28291393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.
    Aznar MC; Girinsky T; Berthelsen AK; Aleman B; Beijert M; Hutchings M; Lievens Y; Meijnders P; Meidahl Petersen P; Schut D; Maraldo MV; van der Maazen R; Specht L
    Acta Oncol; 2017 Apr; 56(4):608-613. PubMed ID: 28105886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Involved-nodal radiation therapy leads to lower doses to critical organs-at-risk compared to involved-field radiation therapy.
    Mulvihill DJ; McMichael K; Goyal S; Drachtman R; Weiss A; Khan AJ
    Radiother Oncol; 2014 Aug; 112(2):279-83. PubMed ID: 25082095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involved-node radiotherapy and modern radiation treatment techniques in patients with Hodgkin lymphoma.
    Paumier A; Ghalibafian M; Beaudre A; Ferreira I; Pichenot C; Messai T; Lessard NA; Lefkopoulos D; Girinsky T
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):199-205. PubMed ID: 21481723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.
    Girinsky T; Aupérin A; Ribrag V; Elleuch M; Fermé C; Bonniaud G; Ruelle C; Alberini JL; Celebic A; Edeline V
    Int J Radiat Oncol Biol Phys; 2014 Aug; 89(5):1047-1052. PubMed ID: 25035208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG).
    Specht L; Yahalom J; Illidge T; Berthelsen AK; Constine LS; Eich HT; Girinsky T; Hoppe RT; Mauch P; Mikhaeel NG; Ng A;
    Int J Radiat Oncol Biol Phys; 2014 Jul; 89(4):854-62. PubMed ID: 23790512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involved node radiation therapy: an effective alternative in early-stage hodgkin lymphoma.
    Maraldo MV; Aznar MC; Vogelius IR; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1057-65. PubMed ID: 23200817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fondazione Italiana Linfomi (FIL) expert consensus on the use of intensity-modulated and image-guided radiotherapy for Hodgkin's lymphoma involving the mediastinum.
    Filippi AR; Meregalli S; DI Russo A; Levis M; Ciammella P; Buglione M; Guerini AE; De Marco G; De Sanctis V; Vagge S; Ricardi U; Simontacchi G;
    Radiat Oncol; 2020 Mar; 15(1):62. PubMed ID: 32164700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritransplant Radiation Therapy in Patients With Refractory or Relapsed Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplant: Long-Term Results of a Retrospective Study of the Fondazione Italiana Linfomi.
    Levis M; Campbell BA; Matrone F; Grapulin L; Di Russo A; Buglione M; Iamundo De Cumis I; Simontacchi G; Ciammella P; Magli A; Pascale G; Meregalli S; MacManus M; Fanetti G; De Felice F; Furfaro G; Ciccone G; Ricardi U
    Int J Radiat Oncol Biol Phys; 2023 Aug; 116(5):1008-1018. PubMed ID: 36822373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involved-nodal radiation therapy as a component of combination therapy for limited-stage Hodgkin's lymphoma: a question of field size.
    Campbell BA; Voss N; Pickles T; Morris J; Gascoyne RD; Savage KJ; Connors JM
    J Clin Oncol; 2008 Nov; 26(32):5170-4. PubMed ID: 18838714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The development of quality assurance programs for radiotherapy within the German Hodgkin Study Group (GHSG). Introduction, continuing work, and results of the radiotherapy reference panel.
    Müller RP; Eich HT
    Strahlenther Onkol; 2005 Sep; 181(9):557-66. PubMed ID: 16170482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved-node and involved-field volumetric modulated arc vs. fixed beam intensity-modulated radiotherapy for female patients with early-stage supra-diaphragmatic Hodgkin lymphoma: a comparative planning study.
    Weber DC; Peguret N; Dipasquale G; Cozzi L
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1578-86. PubMed ID: 19596171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involved node radiation therapy in the combined modality treatment for early-stage Hodgkin lymphoma: Analysis of relapse location and long-term outcome.
    Nielsen K; Maraldo MV; Berthelsen AK; Loft A; de Nully Brown P; Vogelius IR; Petersen PM; Specht L
    Radiother Oncol; 2020 Sep; 150():236-244. PubMed ID: 32622782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quality control of involved-field radiotherapy for patients with early stage Hodgkin's lymphoma based on a central prospective review. Comparison of the results between two study generations of the German Hodgkin Study Group.
    Kriz J; Bangard C; Haverkamp U; Bongartz R; Baues C; Engert A; Mueller RP; Eich HT
    Strahlenther Onkol; 2012 Aug; 188(8):660-5. PubMed ID: 22692351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New therapeutic strategies for Hodgkin lymphoma in cooperation of radiation oncology and medical oncology].
    Eich HT; Müller RP; Ansén S; Josting A; Engert A; Hansemann K; Pfistner B; Wolf J; Willich N; Diehl V
    Rontgenpraxis; 2003; 55(3):114-24. PubMed ID: 15119314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omitting radiotherapy in early positron emission tomography-negative stage I/II Hodgkin lymphoma is associated with an increased risk of early relapse: Clinical results of the preplanned interim analysis of the randomized EORTC/LYSA/FIL H10 trial.
    Raemaekers JM; André MP; Federico M; Girinsky T; Oumedaly R; Brusamolino E; Brice P; Fermé C; van der Maazen R; Gotti M; Bouabdallah R; Sebban CJ; Lievens Y; Re A; Stamatoullas A; Morschhauser F; Lugtenburg PJ; Abruzzese E; Olivier P; Casasnovas RO; van Imhoff G; Raveloarivahy T; Bellei M; van der Borght T; Bardet S; Versari A; Hutchings M; Meignan M; Fortpied C
    J Clin Oncol; 2014 Apr; 32(12):1188-94. PubMed ID: 24637998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doses to carotid arteries after modern radiation therapy for Hodgkin lymphoma: is stroke still a late effect of treatment?
    Maraldo MV; Brodin P; Aznar MC; Vogelius IR; Munck af Rosenschöld P; Petersen PM; Specht L
    Int J Radiat Oncol Biol Phys; 2013 Oct; 87(2):297-303. PubMed ID: 23910709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Centralized radiation oncologic review of cross-sectional imaging of Hodgkin's disease leads to significant changes in required involved field-results of a quality assurance program of the German Hodgkin Study Group.
    Eich HT; Staar S; Gossmann A; Hansemann K; Skripnitchenko R; Kocher M; Semrau R; Engert A; Josting A; Franklin J; Krug B; Diehl V; Müller RP;
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(4):1121-7. PubMed ID: 15001253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
    Fiaccadori V; Neven A; Fortpied C; Aurer I; Andre M; Federico M; Counsell N; Phillips EH; Clifton-Hadley L; Barrington SF; Illidge T; Radford J; Raemaekers JMM
    Br J Haematol; 2023 Mar; 200(6):731-739. PubMed ID: 36541117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.